Abbott: Obesity trials
The registry lists 10 Obesity studies with Abbott as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 2 3Phase 3 7Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Fenofibrate on Sleep Apnea SyndromeTerminatedNCT00816829Phase 2Results posted
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese PatientsCompletedNCT00234832Phase 3Results posted
- Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese HypertensivesCompletedNCT00679653Phase 3
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationCompletedNCT00677391Phase 3
- Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese SubjectsTerminatedNCT00645255Phase 3
- BMS-646256 in Obese and Overweight Type 2 DiabeticsWithdrawnNCT00541567Phase 2/3
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedNCT00402584Phase 3
- A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNCT00349635Phase 2
- A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.CompletedNCT00261911Phase 3
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.CompletedNCT00234988Phase 4